Such precise targeting reflects the broader biological roles of PSMA in prostate cancer, including its involvement in tumor cell invasion and angiogenesis, thereby confirming its significance in imaging for diagnostic, prognostic, and therapeutic markers, thus opening avenues for tailored therapeutic interventions and personalized management strategies aimed at improving patient outcomes in prostate cancer. Here, FOLH1 is linked to prostate carcinoma.